Clinical trial
Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers
NCT02637466
Study timeline
Study start (unknown)2016-07-01Date precision: month
Registry last updated2016-09-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Unipolar Major Depressionunresolved
Stage I, II or III Breast Cancerunresolved
Interventions
VortioxetineDRUG · verified · RxNorm: vortioxetine
Sponsors & collaborators
University of Miamilead sponsor
Takedacollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02637466 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.